SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Valerie Jenkins, Ryan Thwaites, Mara Cercignani, Sandra Sacre, Neil Harrison, Hefina Whiteley-Jones, Lisa Mullen, Giselle Chamberlain, Kevin Davies, Charles Zammit, Lucy Matthews, Helena Harder, A feasibility study exploring the role of pre-operative assessment when examining the mechanism of ‘chemo-brain’ in breast cancer patients, SpringerPlus, 2016, 5, 1

    CrossRef

  2. 2
    志辽 陈, A Study of Chemotherapy-Related Cognitive Impairment in Gynecologic Cancer Patients, Medical Diagnosis, 2016, 06, 01, 40

    CrossRef

  3. 3
    A. M. Williams, M. C. Janelsins, E. van Wijngaarden, Cognitive function in cancer survivors: analysis of the 1999–2002 National Health and Nutrition Examination Survey, Supportive Care in Cancer, 2016, 24, 5, 2155

    CrossRef

  4. 4
    Rex M. Philpot, Melissa Ficken, Lynn Wecker, Doxorubicin and cyclophosphamide lead to long-lasting impairment of spatial memory in female, but not male mice, Behavioural Brain Research, 2016, 307, 165

    CrossRef

  5. 5
    Christie Yao, Jill B. Rich, Ian F. Tannock, Bostjan Seruga, Kattleya Tirona, Lori J. Bernstein, Pretreatment Differences in Intraindividual Variability in Reaction Time between Women Diagnosed with Breast Cancer and Healthy Controls, Journal of the International Neuropsychological Society, 2016, 22, 05, 530

    CrossRef

  6. 6
    Kerstin Hermelink, Markus Bühner, Nadia Harbeck, Response, Journal of the National Cancer Institute, 2016, 108, 8, djw049

    CrossRef

  7. 7
    Debra E. Lyon, Ronald Cohen, Huaihou Chen, Debra L. Kelly, Angela Starkweather, Hyo-Chol Ahn, Colleen K. Jackson-Cook, The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study, Journal of Cancer Research and Clinical Oncology, 2016,

    CrossRef

  8. 8
    Miyuki Ono, James M. Ogilvie, Jennifer S. Wilson, Heather J. Green, Suzanne K. Chambers, Tamara Ownsworth, David H. K. Shum, A Meta-Analysis of Cognitive Impairment and Decline Associated with Adjuvant Chemotherapy in Women with Breast Cancer, Frontiers in Oncology, 2015, 5,

    CrossRef

  9. 9
    Emilie Le Rhun, Xavier Delbeuck, Claudia Lefeuvre-Plesse, Andrew Kramar, Emilie Skrobala, Florence Pasquier, Jacques Bonneterre, A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy, Breast Cancer Research and Treatment, 2015, 152, 3, 569

    CrossRef

  10. 10
    Kajal Gokal, Fehmidah Munir, Deborah Wallis, Samreen Ahmed, Ion Boiangiu, Kiran Kancherla, Can physical activity help to maintain cognitive functioning and psychosocial well-being among breast cancer patients treated with chemotherapy? A randomised controlled trial: study protocol, BMC Public Health, 2015, 15, 1

    CrossRef

  11. 11
    Hiromichi Matsuoka, Kazuhiro Yoshiuchi, Atsuko Koyama, Masatomo Otsuka, Kazuhiko Nakagawa, Chemotherapeutic drugs that penetrate the blood–brain barrier affect the development of hyperactive delirium in cancer patients, Palliative and Supportive Care, 2015, 13, 04, 859

    CrossRef

  12. 12
    K. Hermelink, Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain, JNCI Monographs, 2015, 2015, 51, 67

    CrossRef

  13. 13
    J. Dietrich, M. Prust, J. Kaiser, Chemotherapy, cognitive impairment and hippocampal toxicity, Neuroscience, 2015, 309, 224

    CrossRef

  14. You have free access to this content14
    Jeffrey S. Wefel, Shelli R. Kesler, Kyle R. Noll, Sanne B. Schagen, Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults, CA: A Cancer Journal for Clinicians, 2015, 65, 2
  15. 15
    Lisa M. Hess, Helen Q. Huang, Alexandra L. Hanlon, William R. Robinson, Rhonda Johnson, Setsuko K. Chambers, Robert S. Mannel, Larry Puls, Susan A. Davidson, Michael Method, Shashikant Lele, Laura Havrilesky, Tina Nelson, David S. Alberts, Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study, Gynecologic Oncology, 2015, 139, 3, 541

    CrossRef

  16. 16
    K. Hermelink, V. Voigt, J. Kaste, F. Neufeld, R. Wuerstlein, M. Buhner, K. Munzel, D. Rjosk-Dendorfer, S. Grandl, M. Braun, F. E. von Koch, K. Hartl, S. Hasmuller, I. Bauerfeind, G. Debus, P. Herschbach, N. Harbeck, Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-related Post-traumatic Stress, JNCI Journal of the National Cancer Institute, 2015, 107, 7, djv099

    CrossRef

  17. 17
    D.R. Fenlon, P. Khambhaita, M.S. Hunter, Helping Patients to Help Themselves after Breast Cancer Treatment, Clinical Oncology, 2015, 27, 11, 640

    CrossRef

  18. 18
    S. K. Patel, A. L. Wong, F. L. Wong, E. C. Breen, A. Hurria, M. Smith, C. Kinjo, I. B. Paz, L. Kruper, G. Somlo, J. E. Mortimer, M. R. Palomares, M. R. Irwin, S. Bhatia, Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer, JNCI Journal of the National Cancer Institute, 2015, 107, 8, djv131

    CrossRef

  19. 19
    Rex M. Philpot, Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits, Neurochemical Research, 2015, 40, 10, 2018

    CrossRef

  20. 20
    Andrew Schrepf, Susan K. Lutgendorf, Leah M. Pyter, Pre-treatment effects of peripheral tumors on brain and behavior: Neuroinflammatory mechanisms in humans and rodents, Brain, Behavior, and Immunity, 2015, 49, 1

    CrossRef

  21. 21
    Jin-Hee Park, Sun Hyoung Bae, Yong-Sik Jung, Young-Mi Jung, Prevalence and Characteristics of Chemotherapy-related Cognitive Impairment in Patients with Breast Cancer, Journal of Korean Academy of Nursing, 2015, 45, 1, 118

    CrossRef

  22. 22
    Elodie Martin, Véronique Morel, Dominique Joly, Christine Villatte, Noémie Delage, Claude Dubray, Bruno Pereira, Gisèle Pickering, Rationale and design of a randomized double-blind clinical trial in breast cancer: Dextromethorphan in chemotherapy-induced peripheral neuropathy, Contemporary Clinical Trials, 2015, 41, 146

    CrossRef

  23. 23
    Nathan W. Churchill, Bernadine Cimprich, Mary K. Askren, Patricia A. Reuter-Lorenz, Mi Sook Jung, Scott Peltier, Marc G. Berman, Scale-free brain dynamics under physical and psychological distress: Pre-treatment effects in women diagnosed with breast cancer, Human Brain Mapping, 2015, 36, 3
  24. 24
    Lauro A. Munoz, Claudine Campbell, Patricia Bowyer, The Role of Occupational Therapy in Older Adults With Cognitive Impairments and an Oncology Diagnosis, Topics in Geriatric Rehabilitation, 2015, 31, 4, 281

    CrossRef

  25. 25
    R. Wagland, A. Richardson, J. Armes, M. Hankins, E. Lennan, P. Griffiths, Treatment-related problems experienced by cancer patients undergoing chemotherapy: a scoping review, European Journal of Cancer Care, 2015, 24, 5
  26. 26
    Ruchika Kaul-Ghanekar, Snehal Suryavanshi, Prerna Raina, Noninvasive Molecular Markers in Gynecologic Cancers, 2015,

    CrossRef

  27. 27
    Evolution of Vulnerability, 2015,

    CrossRef

  28. 28
    David C. Geary, Evolution of Vulnerability, 2015,

    CrossRef

  29. 29
    David C. Geary, Evolution of Vulnerability, 2015,

    CrossRef

  30. 30
    Jeffrey S. Wefel, Damon J. Vidrine, Salma K. Marani, Richard J. Swartz, Tracy L. Veramonti, Christina A. Meyers, Harald J. Hoekstra, Josette E. H. M. Hoekstra-Weebers, Ellen R. Gritz, A prospective study of cognitive function in men with non-seminomatous germ cell tumors, Psycho-Oncology, 2014, 23, 6
  31. 31
    Theresa A. Koleck, Catherine M. Bender, Susan M. Sereika, Gretchen Ahrendt, Rachel C. Jankowitz, Kandace P. McGuire, Christopher M. Ryan, Yvette P. Conley, Apolipoprotein E Genotype and Cognitive Function in Postmenopausal Women With Early-Stage Breast Cancer, Oncology Nursing Forum, 2014, 41, 6, E313

    CrossRef

  32. 32
    Jochen Kaiser, Jörg Dietrich, Challenges in research on the neural basis of „chemobrain”, Translational Neuroscience, 2014, 5, 3

    CrossRef

  33. 33
    Kim Edelstein, Lori J. Bernstein, Cognitive Dysfunction after Chemotherapy For Breast Cancer, Journal of the International Neuropsychological Society, 2014, 20, 04, 351

    CrossRef

  34. 34
    J. Vardy, H. M. Dhillon, G. R. Pond, S. B. Rourke, W. Xu, A. Dodd, C. Renton, A. Park, T. Bekele, J. Ringash, H. Zhang, R. Burkes, S. J. Clarke, I. F. Tannock, Cognitive function and fatigue after diagnosis of colorectal cancer, Annals of Oncology, 2014, 25, 12, 2404

    CrossRef

  35. 35
    Noriko Ando-Tanabe, Yumi Iwamitsu, Masaru Kuranami, Shigemi Okazaki, Hiroe Yasuda, Yuki Nakatani, Kenji Yamamoto, Masahiko Watanabe, Hitoshi Miyaoka, Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls, Breast Cancer, 2014, 21, 4, 453

    CrossRef

  36. 36
    Juan Antonio Cruzado, Sonia López-Santiago, Virginia Martínez-Marín, Gema José-Moreno, Ana Belén Custodio, Jaime Feliu, Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients, Supportive Care in Cancer, 2014, 22, 7, 1815

    CrossRef

  37. 37
    Yingchun Zeng, Meiling Huang, Andy S. K. Cheng, Ying Zhou, Winnie K. W. So, Meta-analysis of the effects of exercise intervention on quality of life in breast cancer survivors, Breast Cancer, 2014, 21, 3, 262

    CrossRef

  38. 38
    Jochen Kaiser, Christoph Bledowski, Jörg Dietrich, Neural correlates of chemotherapy-related cognitive impairment, Cortex, 2014, 54, 33

    CrossRef

  39. 39
    Mary K. Askren, Misook Jung, Marc G. Berman, Min Zhang, Barbara Therrien, Scott Peltier, Lynn Ossher, Daniel F. Hayes, Patricia A. Reuter-Lorenz, Bernadine Cimprich, Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation, Breast Cancer Research and Treatment, 2014, 147, 2, 445

    CrossRef

  40. 40
    Michelle C. Janelsins, Shelli R. Kesler, Tim A. Ahles, Gary R. Morrow, Prevalence, mechanisms, and management of cancer-related cognitive impairment, International Review of Psychiatry, 2014, 26, 1, 102

    CrossRef

  41. 41
    L. Fallowfield, V. Jenkins, Psychosocial/Survivorship Issues in Breast Cancer: Are We Doing Better?, JNCI Journal of the National Cancer Institute, 2014, 107, 1, dju335

    CrossRef

  42. 42
    M. W. M. van der Poel, S. Oerlemans, H. C. Schouten, F. Mols, J. F. M. Pruijt, H. Maas, L. V. van de Poll-Franse, Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry, Annals of Hematology, 2014, 93, 5, 811

    CrossRef

  43. 43
    Jin-Shei Lai, Lynne I. Wagner, Paul B. Jacobsen, David Cella, Self-reported cognitive concerns and abilities: two sides of one coin?, Psycho-Oncology, 2014, 23, 10
  44. 44
    Terence Ng, Yin Ting Cheung, Quan Sing Ng, Han Kiat Ho, Alexandre Chan, Vascular endothelial growth factor inhibitors and cognitive impairment: evidence and controversies, Expert Opinion on Drug Safety, 2014, 13, 1, 83

    CrossRef

  45. 45
    Ruchika Kaul-Ghanekar, Snehal Suryavanshi, Prerna Raina, Cancer Biomarkers, 2014,

    CrossRef

  46. 46
    Lise Paquet, Barbara Collins, Xinni Song, Anne Chinneck, Marc Bedard, Shailendra Verma, A pilot study of prospective memory functioning in early breast cancer survivors, The Breast, 2013, 22, 4, 455

    CrossRef

  47. 47
    Pei Li, Benjamin J. Albrecht, Xisheng Yan, Mei Gao, Han-Rong Weng, Michael G. Bartlett, A rapid analytical method for the quantification of paclitaxel in rat plasma and brain tissue by high-performance liquid chromatography and tandem mass spectrometry, Rapid Communications in Mass Spectrometry, 2013, 27, 19
  48. 48
    Yin Ting Cheung, Maung Shwe, Earl Hsien Jie Tan, Wai Keung Chui, Raymond Ng, Alexandre Chan, Acknowledging the relevance of cognitive changes in cancer patients: perspectives of oncology practitioners in Asia, Journal of Cancer Survivorship, 2013, 7, 1, 146

    CrossRef

  49. 49
    Daniela Stan, Charles L. Loprinzi, Kathryn J. Ruddy, Breast Cancer Survivorship Issues, Hematology/Oncology Clinics of North America, 2013, 27, 4, 805

    CrossRef

  50. 50
    Catherine M. Bender, Bethany D. Thelen, Cancer and Cognitive Changes: The Complexity of the Problem, Seminars in Oncology Nursing, 2013, 29, 4, 232

    CrossRef

  51. 51
    Susan K. Conroy, Brenna C. McDonald, Tim A. Ahles, John D. West, Andrew J. Saykin, Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates, Brain Imaging and Behavior, 2013, 7, 4, 491

    CrossRef

  52. 52
    Barbara Collins, Joyce MacKenzie, Giorgio A. Tasca, Carole Scherling, Andra Smith, Cognitive effects of chemotherapy in breast cancer patients: a dose–response study, Psycho-Oncology, 2013, 22, 7
  53. 53
    Patricia A. Reuter-Lorenz, Bernadine Cimprich, Cognitive function and breast cancer: promise and potential insights from functional brain imaging, Breast Cancer Research and Treatment, 2013, 137, 1, 33

    CrossRef

  54. 54
    Angela Scherwath, Lena Schirmer, Margitta Kruse, Gundula Ernst, Matthias Eder, Andreas Dinkel, Sabine Kunze, Friedrich Balck, Martin Bornhäuser, Gerhard Ehninger, Karin Dolan, Martin Gramatzki, Hans-Jochem Kolb, Pia Heußner, Hans Wilhelm, Dietrich W. Beelen, Frank Schulz-Kindermann, Axel R. Zander, Uwe Koch, Anja Mehnert, Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study, Psycho-Oncology, 2013, 22, 7
  55. 55
    Gyung Duck Kim, Bok Yae Chung, Kyung Hae Kim, Hye Sun Byun, Eun Hee Choi, Comparison of Climacteric Symptoms and Cognitive Impairment in Breast Cancer Survivors and Healthy Women, Asian Oncology Nursing, 2013, 13, 1, 11

    CrossRef

  56. 56
    Rocío A. López Zunini, Carole Scherling, Nancy Wallis, Barbara Collins, Joyce MacKenzie, Catherine Bielajew, Andra M. Smith, Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study, Brain Imaging and Behavior, 2013, 7, 4, 460

    CrossRef

  57. 57
    Justin Davis, Fiona M Ahlberg, Michael Berk, David M Ashley, Mustafa Khasraw, Emerging pharmacotherapy for cancer patients with cognitive dysfunction, BMC Neurology, 2013, 13, 1, 153

    CrossRef

  58. 58
    Aude Caplette-Gingras, Josée Savard, Marie-Hélène Savard, Hans Ivers, Is Insomnia Associated With Cognitive Impairments in Breast Cancer Patients?, Behavioral Sleep Medicine, 2013, 11, 4, 239

    CrossRef

  59. 59
    Adeline Rollin-Sillaire, Xavier Delbeuck, Marianne Pollet, Marie-Anne Mackowiak, Pierre Lenfant, Marie-Pierre Noel, Thierry Facon, Xavier Leleu, Florence Pasquier, Emilie Le Rhun, Memory loss during lenalidomide treatment: a report on two cases, BMC Pharmacology and Toxicology, 2013, 14, 1, 41

    CrossRef

  60. 60
    Wendy L. Nelson, Jerry Suls, New Approaches to Understand Cognitive Changes Associated With Chemotherapy for Non-Central Nervous System Tumors, Journal of Pain and Symptom Management, 2013, 46, 5, 707

    CrossRef

  61. 61
    Barbara Collins, Joyce Mackenzie, Catherine Kyeremanteng, Study of the cognitive effects of chemotherapy: Considerations in selection of a control group, Journal of Clinical and Experimental Neuropsychology, 2013, 35, 4, 435

    CrossRef

  62. 62
    I. Léger, L. de Batz, S. Dauchy, Une consultation mémoire en cancérologie: entre plainte et trouble..., Psycho-Oncologie, 2013, 7, 4, 210

    CrossRef

  63. 63
    Kerstin Hermelink, Psychoonkologie, 2013,

    CrossRef

  64. 64
    Kelsey L Pomykala, Daniel HS Silverman, Alterations in brain structure and function after chemotherapy for cancer, Future Neurology, 2012, 7, 4, 443

    CrossRef

  65. 65
    Yin Ting Cheung, Earl Hsien-Jie Tan, Alexandre Chan, An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors, Supportive Care in Cancer, 2012, 20, 7, 1361

    CrossRef

  66. You have free access to this content66
    Tim A. Ahles, Brain vulnerability to chemotherapy toxicities, Psycho-Oncology, 2012, 21, 11
  67. 67
    Mary Louise Kanaskie, Chemotherapy-Related Cognitive Change: A Principle-Based Concept Analysis, Oncology Nursing Forum, 2012, 39, 3, E241

    CrossRef

  68. 68
    Jeffrey S. Wefel, Sanne B. Schagen, Chemotherapy-Related Cognitive Dysfunction, Current Neurology and Neuroscience Reports, 2012, 12, 3, 267

    CrossRef

  69. 69
    Michelle Monje, Jörg Dietrich, Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis, Behavioural Brain Research, 2012, 227, 2, 376

    CrossRef

  70. 70
    S. Legriel, E. Azoulay, Complications neurologiques des traitements anticancéreux, Réanimation, 2012, 21, 5, 613

    CrossRef

  71. 71
    Erin Gibson, Michelle Monje, Effect of cancer therapy on neural stem cells, Current Opinion in Oncology, 2012, 24, 6, 672

    CrossRef

  72. 72
    Elham Hedayati, Hassan Alinaghizadeh, Anna Schedin, Håkan Nyman, Maria Albertsson, Effects of adjuvant treatment on cognitive function in women with early breast cancer, European Journal of Oncology Nursing, 2012, 16, 3, 315

    CrossRef

  73. 73
    Joseph M. Andreano, James Waisman, Lisa Donley, Larry Cahill, Effects of breast cancer treatment on the hormonal and cognitive consequences of acute stress, Psycho-Oncology, 2012, 21, 10
  74. 74
    Lisa K. Sprod, Michelle C. Janelsins, Oxana G. Palesh, Jennifer K. Carroll, Charles E. Heckler, Luke J. Peppone, Supriya G. Mohile, Gary R. Morrow, Karen M. Mustian, Health-related quality of life and biomarkers in breast cancer survivors participating in tai chi chuan, Journal of Cancer Survivorship, 2012, 6, 2, 146

    CrossRef

  75. 75
    Emilio J Sanchez-Barcelo, Maria D Mediavilla, Carolina Alonso-Gonzalez, Russel J Reiter, Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation, Expert Opinion on Investigational Drugs, 2012, 21, 6, 819

    CrossRef

  76. 76
    Yin Ting Cheung, Wai Keung Chui, Alexandre Chan, Neuro-cognitive impairment in breast cancer patients: Pharmacological considerations, Critical Reviews in Oncology/Hematology, 2012, 83, 1, 99

    CrossRef

  77. 77
    Caroline H. Walker, Barbara A. Drew, James W. Antoon, Alan V. Kalueff, Barbara S. Beckman, Neurocognitive Effects of Chemotherapy and Endocrine Therapies in the Treatment of Breast Cancer: Recent Perspectives, Cancer Investigation, 2012, 30, 2, 135

    CrossRef

  78. 78
    Stewart M. Bond, Mary S. Dietrich, Barbara A. Murphy, Neurocognitive function in head and neck cancer patients prior to treatment, Supportive Care in Cancer, 2012, 20, 1, 149

    CrossRef

  79. 79
    N. BIGLIA, V.E. BOUNOUS, A. MALABAILA, D. PALMISANO, D.M.E. TORTA, M. D'ALONZO, P. SISMONDI, R. TORTA, Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study, European Journal of Cancer Care, 2012, 21, 4
  80. 80
    Amanda D. Hutchinson, Jessica R. Hosking, Ganessan Kichenadasse, Julie K. Mattiske, Carlene Wilson, Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review, Cancer Treatment Reviews, 2012, 38, 7, 926

    CrossRef

  81. 81
    Thane Fremouw, Christy L. Fessler, Robert J. Ferguson, Yamil Burguete, Preserved learning and memory in mice following chemotherapy: 5-Fluorouracil and doxorubicin single agent treatment, doxorubicin–cyclophosphamide combination treatment, Behavioural Brain Research, 2012, 226, 1, 154

    CrossRef

  82. 82
    J. Weis, H. Faller, Psychosoziale Folgen bei Langzeitüberlebenden einer Krebserkrankung, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2012, 55, 4, 501

    CrossRef

  83. 83
    Karin Gehring, Jan Anne Roukema, Margriet M Sitskoorn, Review of recent studies on interventions for cognitive deficits in patients with cancer, Expert Review of Anticancer Therapy, 2012, 12, 2, 255

    CrossRef

  84. 84
    Dominique Rey, Anne-Déborah Bouhnik, Julien Mancini, Marc-Karim Bendiane, Valérie Séror, Patrice Viens, Self-Reported Cognitive Impairment After Breast Cancer Treatment in Young Women from the ELIPPSE40 Cohort: The Long-Term Impact of Chemotherapy, The Breast Journal, 2012, 18, 5
  85. 85
    Stephanie A. Reid-Arndt, Cathy R. Cox, Stress, Coping and Cognitive Deficits in Women After Surgery for Breast Cancer, Journal of Clinical Psychology in Medical Settings, 2012, 19, 2, 127

    CrossRef

  86. 86
    K Ribi, J Aldridge, K-A Phillips, A Thompson, V Harvey, B Thürlimann, F Cardoso, O Pagani, A S Coates, A Goldhirsch, K N Price, R D Gelber, J Bernhard, Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer, British Journal of Cancer, 2012, 106, 10, 1618

    CrossRef

  87. 87
    Catherine E. Jansen, Bruce A. Cooper, Marylin J. Dodd, Christine A. Miaskowski, A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients, Supportive Care in Cancer, 2011, 19, 10, 1647

    CrossRef

  88. 88
    T. Skaali, S. D. Fossa, S. Andersson, M. Cvancarova, C. W. Langberg, G. Lehne, A. A. Dahl, A prospective study of neuropsychological functioning in testicular cancer patients, Annals of Oncology, 2011, 22, 5, 1062

    CrossRef

  89. 89
    Michelle C. Janelsins, Sadhna Kohli, Supriya G. Mohile, Kenneth Usuki, Tim A. Ahles, Gary R. Morrow, An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status, Seminars in Oncology, 2011, 38, 3, 431

    CrossRef

  90. 90
    Gyung Duck Kim, Bok Yae Chung, Kyung Hae Kim, Hye Sun Byun, Eun Hee Choi, Analysis of a Trend of Instrument Usage to Assess Cognitive Function of Breast Cancer Patients Undergoing Chemotherapy, Journal of Korean Oncology Nursing, 2011, 11, 3, 179

    CrossRef

  91. 91
    Hui K. Gan, Lori J. Bernstein, Jennifer Brown, Jolie Ringash, Mehrdad Vakilha, Lisa Wang, David Goldstein, John Kim, Andrew Hope, Brian O'Sullivan, John Waldron, Albiruni R. Abdul Razak, Eric X. Chen, Lillian L. Siu, Cognitive Functioning After Radiotherapy or Chemoradiotherapy for Head-and-Neck Cancer, International Journal of Radiation Oncology*Biology*Physics, 2011, 81, 1, 126

    CrossRef

  92. 92
    Jeffrey S. Wefel, Damon J. Vidrine, Tracy L. Veramonti, Christina A. Meyers, Salma K. Marani, Harald J. Hoekstra, Josette E. H. M. Hoekstra-Weebers, Lokesh Shahani, Ellen R. Gritz, Cognitive impairment in men with testicular cancer prior to adjuvant therapy, Cancer, 2011, 117, 1
  93. 93
    Andreas A. Argyriou, Konstantinos Assimakopoulos, Gregoris Iconomou, Fotini Giannakopoulou, Haralabos P. Kalofonos, Either Called “Chemobrain” or “Chemofog,” the Long-Term Chemotherapy-Induced Cognitive Decline in Cancer Survivors Is Real, Journal of Pain and Symptom Management, 2011, 41, 1, 126

    CrossRef

  94. 94
    M. Lange, B. Giffard, F. Eustache, N. Morel, S. Noal, F. Joly, Impact de la chimiothérapie adjuvante sur les fonctions cognitives dans le cancer du sein: revue de la littérature, Psycho-Oncologie, 2011, 5, 1, 3

    CrossRef

  95. 95
    Jeffrey S Wefel, Janette Vardy, Tim Ahles, Sanne B Schagen, International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, The Lancet Oncology, 2011, 12, 7, 703

    CrossRef

  96. 96
    Lea Ann Ouimet, Angela Stewart, Barbara Collins, Dwayne Schindler, Catherine Bielajew, Investigation of a neuropsychological screen for chemo-fog, Oncology Reviews, 2011, 5, 4, 205

    CrossRef

  97. 97
    Riejanne Seigers, Joanna E. Fardell, Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research, Neuroscience & Biobehavioral Reviews, 2011, 35, 3, 729

    CrossRef

  98. 98
    Seongmi Moon, Sun-Hee Kim, Mi-Ja Kim, Perceived Cognitive Function and Related Factors in Korean Women With Breast Cancer, Asian Nursing Research, 2011, 5, 2, 141

    CrossRef

  99. 99
    Jeffrey M. Long, Garrick D. Lee, Bennett Kelley-Bell, Edward L. Spangler, Evelyn J. Perez, Dan L. Longo, Rafael de Cabo, Sige Zou, Peter R. Rapp, Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats, Pharmacology Biochemistry and Behavior, 2011, 100, 1, 205

    CrossRef

  100. 100
    Diane Von Ah, Catherine Jansen, Deborah Hutchinson Allen, Rosalina M. Schiavone, Jennifer Wulff, Putting Evidence Into Practice, Clinical Journal of Oncology Nursing, 2011, 15, 6, 607

    CrossRef

  101. 101
    Earllaine Croarkin, Min-Hui Huang, Screening Balance Deficits in Older Individuals Diagnosed With Cancer, Topics in Geriatric Rehabilitation, 2011, 27, 3, 244

    CrossRef

  102. 102
    Tone Skaali, Sophie D. Fosså, Stein Andersson, Milada Cvancarova, Carl W. Langberg, Gustav Lehne, Alv A. Dahl, Self-reported cognitive problems in testicular cancer patients: Relation to neuropsychological performance, fatigue, and psychological distress, Journal of Psychosomatic Research, 2011, 70, 5, 403

    CrossRef

  103. 103
    Elham Hedayati, Anna Schedin, Håkan Nyman, Hassan Alinaghizadeh, Maria Albertsson, The effects of breast cancer diagnosis and surgery on cognitive functions, Acta Oncologica, 2011, 50, 7, 1027

    CrossRef

  104. 104
    Edward J. Dropcho, The Neurologic Side Effects of Chemotherapeutic Agents, CONTINUUM: Lifelong Learning in Neurology, 2011, 17, 95

    CrossRef

  105. 105
    Janette Vardy, Haryana Dhillon, Supportive Oncology, 2011,

    CrossRef

  106. 106
    Jeffrey S. Wefel, Angele K. Saleeba, Aman U. Buzdar, Christina A. Meyers, Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer, Cancer, 2010, 116, 14
  107. 107
    Jeanne Debess, Jens Østergaard Riis, Malene Cramer Engebjerg, Marianne Ewertz, Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study, Breast Cancer Research and Treatment, 2010, 121, 1, 91

    CrossRef

  108. 108
    C.M.T. Schilder, C. Seynaeve, S.C. Linn, W. Boogerd, L.V.A.M. Beex, C.M. Gundy, J.W.R. Nortier, C.J.H. van de Velde, F.S.A.M. van Dam, S.B. Schagen, Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors, Critical Reviews in Oncology/Hematology, 2010, 76, 2, 133

    CrossRef

  109. 109
    Riejanne Seigers, Line Pourtau, Sanne B. Schagen, Frits S.A.M. van Dam, Jaap M. Koolhaas, Jan Pieter Konsman, Bauke Buwalda, Inhibition of hippocampal cell proliferation by methotrexate in rats is not potentiated by the presence of a tumor, Brain Research Bulletin, 2010, 81, 4-5, 472

    CrossRef

  110. 110
    Karin Gehring, Neil K Aaronson, Martin J Taphoorn, Margriet M Sitskoorn, Interventions for cognitive deficits in patients with a brain tumor: an update, Expert Review of Anticancer Therapy, 2010, 10, 11, 1779

    CrossRef

  111. 111
    Bernadine Cimprich, Patricia Reuter-Lorenz, James Nelson, Patricia M. Clark, Barbara Therrien, Daniel Normolle, Marc G. Berman, Daniel F. Hayes, Douglas C. Noll, Scott Peltier, Robert C. Welsh, Prechemotherapy alterations in brain function in women with breast cancer, Journal of Clinical and Experimental Neuropsychology, 2010, 32, 3, 324

    CrossRef

  112. 112
    Steven P. Cercy, Brian Bronson, Putative Mechanisms of Cognitive Dysfunction in Chemotherapy-Naïve Diffuse Large B-Cell Lymphoma: A Case Report and Review of the Literature, Applied Neuropsychology, 2010, 17, 3, 223

    CrossRef

  113. 113
    Marleen J.J. Pullens, Jolanda De Vries, Jan A. Roukema, Subjective cognitive dysfunction in breast cancer patients: a systematic review, Psycho-Oncology, 2010, 19, 11
  114. 114
    Felice A. Tager, Paula S. McKinley, Freya R. Schnabel, Mahmoud El-Tamer, Ying Keun K. Cheung, Yixin Fang, Claire R. Golden, Margery E. Frosch, Ulya Habif, Margaret M. Mulligan, Ivy S. Chen, Dawn L. Hershman, The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study, Breast Cancer Research and Treatment, 2010, 123, 1, 25

    CrossRef

  115. 115
    Christina M. Schilder, Caroline Seynaeve, Sabine C. Linn, Willem Boogerd, Chad M. Gundy, Louk V. Beex, Frits S. van Dam, Sanne B. Schagen, The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy, Psycho-Oncology, 2010, 19, 4
  116. You have free access to this content116
    Kerstin Hermelink, Helmut Küchenhoff, Michael Untch, Ingo Bauerfeind, Michael Patrick Lux, Markus Bühner, Juliane Manitz, Veronika Fensterer, Karin Münzel, Two different sides of ‘chemobrain’: determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study, Psycho-Oncology, 2010, 19, 12
  117. 117
    Andrea Vodermaier, Breast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments, Women's Health, 2009, 5, 5, 503

    CrossRef

  118. 118
    Kelly A. Biegler, M. Alejandro Chaoul, Lorenzo Cohen, Cancer, cognitive impairment, and meditation, Acta Oncologica, 2009, 48, 1, 18

    CrossRef

  119. 119
    Barbara Collins, Joyce Mackenzie, Angela Stewart, Catherine Bielajew, Shailendra Verma, Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment, Psycho-Oncology, 2009, 18, 2
  120. 120
    Jeanne Debess, Jens Østergaard Riis, Lars Pedersen, Marianne Ewertz, Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark, Acta Oncologica, 2009, 48, 4, 532

    CrossRef

  121. 121
    Catherine Quesnel, Josée Savard, Hans Ivers, Cognitive impairments associated with breast cancer treatments: results from a longitudinal study, Breast Cancer Research and Treatment, 2009, 116, 1, 113

    CrossRef

  122. 122
    KATHARINE JEAN VEARNCOMBE, NANCY A. PACHANA, Impact of health, treatment and psychological factors on cognitive functioning after chemotherapy for early breast cancer, Australian Psychologist, 2009, 44, 4
  123. 123
    Katharine J. Vearncombe, Nancy A. Pachana, Is cognitive functioning detrimentally affected after early, induced menopause?, Menopause, 2009, 16, 1, 188

    CrossRef

  124. 124
    L. A. Ouimet, A. Stewart, B. Collins, D. Schindler, C. Bielajew, Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models, Journal of Clinical and Experimental Neuropsychology, 2009, 31, 1, 73

    CrossRef

  125. 125
    Steven Castellon, Patricia A. Ganz, Neuropsychological studies in breast cancer: in search of chemobrain, Breast Cancer Research and Treatment, 2009, 116, 1, 125

    CrossRef

  126. 126
    Mimi Mehlsen, Anders Degn Pedersen, Anders Bonde Jensen, Robert Zachariae, No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy, Psycho-Oncology, 2009, 18, 3
  127. 127
    KATHARINE J. VEARNCOMBE, MARGARET ROLFE, MARGARET WRIGHT, NANCY A. PACHANA, BROOKE ANDREW, GEOFFREY BEADLE, Predictors of Cognitive Decline After Chemotherapy in Breast Cancer Patients, Journal of the International Neuropsychological Society, 2009, 15, 06, 951

    CrossRef

  128. 128
    Fleur Huang, Munir Alrefae, Adrian Langleben, David Roberge, Prophylactic Cranial Irradiation in Advanced Breast Cancer: A Case for Caution, International Journal of Radiation Oncology*Biology*Physics, 2009, 73, 3, 752

    CrossRef

  129. 129
    Christopher Loiselle, Jason Rockhill, Radiation, chemotherapy, and symptom management in cancer-related cognitive dysfunction, Current Pain and Headache Reports, 2009, 13, 4, 271

    CrossRef

  130. 130
    Nancy N. Baxter, Sara B. Durham, Kelly-Anne Phillips, Elizabeth B. Habermann, Beth A. Virning, Risk of Dementia in Older Breast Cancer Survivors: A Population-Based Cohort Study of the Association with Adjuvant Chemotherapy, Journal of the American Geriatrics Society, 2009, 57, 3
  131. 131
    Karen Nieuwenhuijsen, Angela de Boer, Evelien Spelten, Mirjam A.G. Sprangers, Jos H. A. M. Verbeek, The role of neuropsychological functioning in cancer survivors' return to work one year after diagnosis, Psycho-Oncology, 2009, 18, 6
  132. 132
    Bostjan Seruga, Haibo Zhang, Lori J. Bernstein, Ian F. Tannock, Cytokines and their relationship to the symptoms and outcome of cancer, Nature Reviews Cancer, 2008, 8, 11, 887

    CrossRef

  133. 133
    Valerie A Jenkins, Laurence M Ambroisine, Louise Atkins, Jack Cuzick, Anthony Howell, Lesley J Fallowfield, Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II), The Lancet Oncology, 2008, 9, 10, 953

    CrossRef

  134. 134
    John J. Foley, Robert B. Raffa, Ellen A. Walker, Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory, Psychopharmacology, 2008, 199, 4, 527

    CrossRef

  135. 135
    Karin Gehring, Margriet M Sitskoorn, Neil K Aaronson, Martin JB Taphoorn, Interventions for cognitive deficits in adults with brain tumours, The Lancet Neurology, 2008, 7, 6, 548

    CrossRef

  136. 136
    Jesse R. Fann, Anne M. Thomas-Rich, Wayne J. Katon, Deborah Cowley, Mary Pepping, Bonnie A. McGregor, Julie Gralow, Major depression after breast cancer: a review of epidemiology and treatment, General Hospital Psychiatry, 2008, 30, 2, 112

    CrossRef

  137. 137
    Jerzy Hildebrand, Neurological complications of medical anti-cancer therapies, Oncology Reviews, 2008, 2, 2, 80

    CrossRef

  138. 138
    Jeffrey S. Wefel, Mariana E. Witgert, Christina A. Meyers, Neuropsychological Sequelae of Non-Central Nervous System Cancer and Cancer Therapy, Neuropsychology Review, 2008, 18, 2, 121

    CrossRef

  139. 139
    Katherine L. Schaefer, PPARγInhibitors as Novel Tubulin-Targeting Agents, PPAR Research, 2008, 2008, 1

    CrossRef

  140. 140
    Catherine E. Jansen, Marylin J. Dodd, Christine A. Miaskowski, Glenna A. Dowling, Joel Kramer, Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide, Psycho-Oncology, 2008, 17, 12
  141. 141
    Kerstin Hermelink, Volkmar Henschel, Michael Untch, Ingo Bauerfeind, Michael Patrick Lux, Karin Munzel, Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients, Cancer, 2008, 113, 9
  142. 142
    Sophie Taillibert, Dorothée Voillery, Chantal Bernard-Marty, Chemobrain: is systemic chemotherapy neurotoxic?, Current Opinion in Oncology, 2007, 19, 6, 623

    CrossRef

  143. 143
    Sanne B Schagen, Janette Vardy, Cognitive dysfunction in people with cancer, The Lancet Oncology, 2007, 8, 10, 852

    CrossRef

  144. 144
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2007, 16, 12